Training program for developing new cancer drugs for children and adults
Official title: Pediatric and Adult Translational Cancer Drug Discovery and Development Training Program (PACT-D3)
Funded at Indiana University Indianapolis · NIH-10915428 · Data updated 2026-11-12
This study is all about training new researchers to find better cancer treatments for both kids and adults, especially for children with tough-to-treat tumors, so they can help improve care and options for young patients.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $164,494 |
| NIH project number | 5T32CA272370-02 |
| Project ID | NIH-10915428 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include children and adults diagnosed with cancer, particularly those with relapsed tumors or limited treatment options.
✕Less likely to help
Patients with non-cancerous conditions or those who are not currently undergoing treatment for cancer may not receive any benefit from this research.
What this research studies
This program trains the next generation of researchers in the field of cancer drug discovery and development, focusing on both pediatric and adult cancers. It aims to address the critical need for effective treatments, particularly for children with relapsed malignant tumors, by leveraging a strong institutional infrastructure and expertise. Participants will engage in comprehensive training that combines basic and clinical research approaches, with a special emphasis on innovative strategies for drug development. The program also collaborates with ongoing clinical trials to enhance treatment options for pediatric patients.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective cancer treatments for both children and adults.
How similar studies have gone: This approach is novel as there are currently no other NIH T32 programs focusing on both pediatric and adult cancer drug discovery and development training.
Where this research is happening
-
Indiana University Indianapolis
Indianapolis, United States Active
Researchers
- Principal investigator: Kelley, Mark R. — Indiana University Indianapolis
- Study coordinator: Kelley, Mark R.
Related research
Other NIH-funded projects on the same topics.
-
Adapting flow cytometry to detect childhood leukemias in Kenya using a single-test screen
A low-cost, blood-based flow cytometry screen in Kenya aims to detect and triage suspected leukemias in children and young adults.
-
Dementia care staff study: adapting a US survey for use in many countries
A study is adapting and testing a survey for dementia care workers in the US, Brazil, Switzerland, and Ghana to help understand why workers stay in their jobs and how to improve care.
-
Dementia care staff study: adapting a survey for use in many countries
A multinational study will adapt and test a U.S. dementia-care worker survey in Brazil, Switzerland, and Ghana to help understand why staff stay in or leave long-term care settings.
-
Study of Dementia Care Staff in 4 Countries: Adapting Caregiver Surveys Across Cultures
A multinational project will adapt and test a dementia care worker survey so researchers can compare care environments across the US, Brazil, Switzerland, and Ghana.
-
Severe malaria and brain risk in children
This grant studies how severe malaria in young children can affect brain development and long-term thinking and behavior, with a focus on kids in Uganda.
-
Tau filament structure in Alzheimer’s and related dementias
Aims to map the detailed 3D shapes of tau protein filaments found in human brain diseases to help develop better diagnostics and treatments for Alzheimer’s-related dementias.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.